An obesity drug deep-dive, and peptides move mainstream - Top-Institutions - MDSpire

An obesity drug deep-dive, and peptides move mainstream

  • By

  • Allison DeAngelis

  • Elaine Chen

  • Adam Feuerstein

  • June 11, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Obesity Medicine

  • #2

    NewYork-Presbyterian Hospital
    NewYork-Presbyterian Hospital

    New York, New York

    Key Differentiators

    • Endocrinology
    • Obesity Medicine

Original Source(s)

An obesity drug deep-dive, and peptides move mainstream

  • by Allison DeAngelis, Elaine Chen, Adam Feuerstein

  • June 11, 2026

Related Content

Impact of whole-body vibration on anthropometric measurements and body composition in overweight and obese university students: a randomized controlled trial

Smartphone-based abdominal inclination angles for assessing abdominal obesity: Convergent validity and reliability study

COPD Severity Tied to Life Expectancy

A pooled US cohort study estimated years of life lost across airflow obstruction severity, including among adults who never smoked.